Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.70 is 24% below its 5-year average of 2.24, near the low end of its 5-year range (1.70–3.51).
As of the fiscal period ended Tuesday, June 30, 2026. 14.58% below its 12-month average of 1.99.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.70.
CURRENT RATIO
1.70
CURRENT RATIO AVG TTM
1.99
CURRENT RATIO AVG 3Y
2.22
CURRENT RATIO AVG 5Y
2.24
CURRENT RATIO AVG 10Y
2.21
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-14.58%
CURRENT VS 3Y AVG
-23.53%
CURRENT VS 5Y AVG
-24.35%
CURRENT VS 10Y AVG
-23.19%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 571 covered companies
CURRENT VS SECTOR MEDIAN
-49.34%
vs the sector median at left
Market Cap
$472.59M
Current Ratio
121.97
TTM Avg
23.71
3Y Avg
19.95
5Y Avg
19.50
Market Cap
$468.01M
Current Ratio
37.17
TTM Avg
24.09
3Y Avg
19.47
5Y Avg
19.38
Market Cap
$454.51M
Current Ratio
6.72
TTM Avg
10.04
3Y Avg
13.74
5Y Avg
16.43
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evolus, Inc. (EOLS) | $474.15M | 1.70 | 1.99 | 2.22 | 2.24 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.59M | 121.97 | 23.71 | 19.95 | 19.50 |
| Arvinas, Inc. (ARVN)vs › | $476.17M | 7.91 | 4.78 | 4.69 | 6.49 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $468.01M | 37.17 | 24.09 | 19.47 | 19.38 |
| Cerus Corporation (CERS)vs › | $467.54M | 1.83 | 2.06 | 1.93 | 2.19 |
| NRC Health (NRC)vs › | $462.45M | 0.65 | 0.55 | 0.77 | 1.10 |
| Kamada Ltd. (KMDA)vs › | $458.09M | 4.06 | 3.90 | 3.27 | 3.77 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $454.51M | 6.72 | 10.04 | 13.74 | 16.43 |
| NeoGenomics, Inc. (NEO)vs › | $451.46M | 3.60 | 3.12 | 4.79 | 5.52 |
| Assembly Biosciences, Inc. (ASMB)vs › | $441.36M | 13.99 | 3.82 | 4.25 | 5.96 |
Current Ratio
1.70
Quick Ratio
1.28
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.70 |
| 2026-03-31 | 2.04 |
| 2025-12-31 | 1.90 |
| 2025-09-30 | 2.02 |
| 2025-06-30 | 2.27 |
| 2025-03-31 | 2.34 |
| 2024-12-31 | 2.40 |
| 2024-09-30 | 2.47 |
| 2024-06-30 | 2.92 |
| 2024-03-31 | 3.21 |
| 2023-12-31 | 2.33 |
| 2023-09-30 | 1.90 |
| 2023-06-30 | 2.33 |
| 2023-03-31 | 2.07 |
| 2022-12-31 | 2.17 |
| 2022-09-30 | 2.26 |
| 2022-06-30 | 2.60 |
| 2022-03-31 | 3.51 |
| 2021-12-31 | 3.10 |
| 2021-09-30 | 1.94 |
| 2021-06-30 | 1.85 |
| 2021-03-31 | 0.89 |
| 2020-12-31 | 0.71 |
| 2020-09-30 | 10.42 |
| 2020-06-30 | 5.55 |
| 2020-03-31 | 5.58 |
| 2019-12-31 | 6.23 |
| 2019-09-30 | 3.66 |
| 2019-06-30 | 5.01 |
| 2019-03-31 | 14.80 |
| 2018-12-31 | 17.88 |
| 2018-09-30 | 19.43 |
| 2018-06-30 | 12.11 |
| 2018-03-31 | 13.81 |
| 2017-12-31 | 0.34 |
| 2017-09-30 | 0.01 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.00 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
